Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Cytarabine × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Myeloid 1 Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 6 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large-Cell, Anaplastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma 4 Sezary Syndrome 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Mycosis Fungoides 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Immunoblastic Lymphadenopathy 3 Hodgkin Disease 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma, Extranodal NK-T-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Intraocular Lymphoma 2 Recurrence 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1

Interventions

pembrolizumab 30 Cyclophosphamide 22 Nivolumab 21 aldesleukin 19 Ipilimumab 19 Interleukin-2 15 fludarabine 14 Specimen Handling 11 fludarabine phosphate 10 Dacarbazine 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 9 Biopsy 9 Temozolomide 8 dabrafenib 5 cemiplimab 5 Vemurafenib 5 Radiotherapy 5 trametinib 4 sargramostim 4 binimetinib 4 avelumab 4 Paclitaxel 4 Cisplatin 4 Bevacizumab 4 lenvatinib 3 encorafenib 3 durvalumab 3 Pemetrexed 3 Lenalidomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡